Newsfeeds - Spark Newswire

2 minute read

Tricida Announces Administrative Stop Of The VALOR-CKD Trial

May 19, 8:34 AM

Tricida, Inc. (NASDAQ:TCDA) announced today that as anticipated it is stopping its VALOR-CKD renal outcomes trial early for administrative reasons pursuant to the existing study protocol to allow for six months of

TCDA

1 minute read

Goldman Sachs Maintains Buy on Tricida, Lowers Price Target to $22

By Benzinga Newsdesk

May 11, 11:24 AM

Goldman Sachs maintains Tricida (NASDAQ:TCDA) with a Buy and lowers the price target from $25 to $22.

TCDA

20 minute read

Earnings Scheduled For May 10, 2022

By Benzinga Insights

May 10, 5:18 AM

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

ABCL

1 minute read

Earnings

Tricida’s Earnings: A Preview

By Benzinga Insights

May 9, 11:07 AM

Tricida (NASDAQ:TCDA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Tricida will report an earnings per share (EPS) of $-0.70.

TCDA

4 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

April 20, 5:43 AM

Gainers

ACC

1 minute read

Goldman Sachs Initiates Coverage On Tricida with Buy Rating, Announces Price Target of $25

By Benzinga Newsdesk

April 13, 5:22 AM

Goldman Sachs analyst Madhu Kumar initiates coverage on Tricida (NASDAQ:TCDA) with a Buy rating and announces Price Target of $25.

TCDA

1 minute read

Events
News

Tricida To Present At Needham’s Virtual Healthcare Conference Monday, Apr. 11 At 1:30 p.m. EDT

By Benzinga Newsdesk

April 1, 10:01 AM

Tricida, Inc. (NASDAQ:TCDA) announced today that it will present at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022 at 10:30 am Pacific Time / 1:30 pm Eastern Time. Tricida will

TCDA

5 minute read

Earnings Scheduled For March 29, 2022

By Benzinga Insights

March 29, 5:03 AM

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

AMPE

4 minute read

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

By Shanthi Rexaline

March 27, 4:40 PM

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

ADMP

6 minute read

80 Biggest Movers From Yesterday

By Lisa Levin

November 17, 5:37 AM

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss.

ANY